A 10-year-old Male Patient with Severe COVID 19 Pneumonia in Jordan

Muna Kilani^1, , Marwan Shalabi¹ and Ahmad Amer²

¹Department of pediatrics, Faculty of Medicine, The Hashemite University, Zarqa, Jordan

²Chicago Medical School, Rosalind Franklin University of Medicine and science, Chicago, USA

Cite this paper

Muna Kilani, Marwan Shalabi and Ahmad Amer. A 10-year-old Male Patient with Severe COVID 19 Pneumonia in Jordan. American Journal of Medical Case Reports. 2021; 9(7):363-366. doi: 10.12691/AJMCR-9-7-6

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection has caused a pandemic in the year 2020. Infection rates and severity of infection in the pediatric population were milder than in adults. This is a case of a 10-year-old male, who was previously healthy, except for being overweight. The patient presented with cough, fever and shortness of breath of two days duration prior to admission. Several of his family members were infected with the SARS-CoV2 virus. The patient developed significant hypoxia and was admitted to the hospital. CXR showed bilateral pulmonary infiltrates consistent with a viral infection. CT scan of his lungs showed areas of significant consolidation scattered over both lung fields, with minimal ground glass opacification. The patient had an elevated CRP, in addition to elevated liver enzymes. His RT-PCR test was positive for the SARA-CoV2 virus. The patient was treated with dexamethasone and IV antibiotics and had a good recovery. This is a case of significant lung disease with consolidation and air bronchograms, in a previously healthy, overweight 10-year-old male from Jordan. The degree of consolidation observed and clinical course of fast recovery and good outcome have not been described in the literature before up to our knowledge.

Keywords

pediatric, Pneumonia, COVID 19

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	“Coronavirus COVID-19 Global cases by the Cener for Systems Sciences and Engineering (CSSE) at Johns Hopkins univeristy.” https://coronavirus.jhu.edu/map.html, [accessed Feb. 10 , 2021].
[2]	K. M. Posfay-Barbe et al., “COVID-19 in Children and the Dynamics of Infection in Families.,” Pediatrics, vol. 146, no. 2, Aug. 2020.
[3]	A. B. Docherty et al., “Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.,” BMJ, vol. 369, p. m1985, May 2020.
[4]	E. K. Stokes et al., “Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.,” MMWR. Morb. Mortal. Wkly. Rep., vol. 69, no. 24, pp. 759-765, Jun. 2020.
[5]	L. Kim et al., “Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020.,” MMWR. Morb. Mortal. Wkly. Rep., vol. 69, no. 32, pp. 1081-1088, Aug. 2020.
[6]	“AAP: Children and COVID-19: State-Level Data Report. American Academy of Pediatrics.”
[7]	Center for Disease Control CDC, “Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1-July 25, 2020.”
[8]	L. S. Shekerdemian et al., “Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units,” JAMA Pediatr., vol. 2019, pp. 1-6, 2020.
[9]	B. K. Tsankov et al., “Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis.,” Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis., vol. 103, pp. 246-256, Feb. 2021.
[10]	R. L. DeBiasi et al., “Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region.,” The Journal of pediatrics, vol. 223. pp. 199-203. e1, Aug-2020.
[11]	N. Nathan et al., “The Wide Spectrum of COVID-19 Clinical Presentation in Children.,” J. Clin. Med., vol. 9, no. 9, Sep. 2020.
[12]	G. Nino, J. Zember, R. Sanchez-Jacob, M. J. Gutierrez, K. Sharma, and M. G. Linguraru, “Pediatric lung imaging features of COVID-19: A systematic review and meta-analysis.,” Pediatr. Pulmonol., vol. 56, no. 1, pp. 252-263, Jan. 2021.
[13]	S. Katal, S. K. Johnston, J. H. Johnston, and A. Gholamrezanezhad, “Imaging Findings of SARS-CoV-2 Infection in Pediatrics: A Systematic Review of Coronavirus Disease 2019 (COVID-19) in 850 Patients.,” Acad. Radiol., vol. 27, no. 11, pp. 1608-1621, Nov. 2020.
[14]	Z. Bayramoglu et al., “Imaging Features of Pediatric COVID-19 on Chest Radiography and Chest CT: A Retrospective, Single-Center Study.,” Acad. Radiol., vol. 28, no. 1, pp. 18-27, Jan. 2021.
[15]	L. R. Feldstein et al., “Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19,” JAMA, Feb. 2021.
[16]	J. F. Branden Engorn, The Harriet Lane Handbook, 20th ed. Elsevier Ltd, 2014.
[17]	K. Chiotos et al., “Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.,” J. Pediatric Infect. Dis. Soc., vol. 10, no. 1, pp. 34-48, Feb. 2021.
[18]	W. Xia, J. Shao, Y. Guo, X. Peng, Z. Li, and D. Hu, “Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.,” Pediatr. Pulmonol., Mar. 2020.
[19]	S.-T. Zang, X. Han, Q. Cui, Q. Chang, Q.-J. Wu, and Y.-H. Zhao, “Imaging characteristics of coronavirus disease 2019 (COVID-19) in pediatric cases: a systematic review and meta-analysis.,” Transl. Pediatr., vol. 10, no. 1, pp. 1-16, Jan. 2021.